Aflac Incorporated
Financials
Valuation Metrics
Aflac Incorporated's Market Cap is $64.49B. At end of 2025 it was $58.14B. Ranked #262 of 3,111 in US market (top 8%), #188 of 1,666 on NYSE (top 11%), #9 of 94 in Insurance (top 10%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $64.49B | US#262/3,111 Sec#9/94 |
| Revenue | $18.22B | US#351/3,111 Sec#18/94 |
| Net Income | $4.64B | US#154/3,111 Sec#6/94 |
| Total Assets | $116.28B | US#158/3,111 Sec#19/94 |
| Net Assets | $29.96B | US#166/3,111 Sec#10/94 |
| Employees | 12,716 | US#524/3,111 Sec#19/94 |
| Value | ||
| P/E | 13.91x | US#601/3,111 Sec#53/94 |
| P/B | 2.15x | US#1,295/3,111 Sec#63/94 |
| PEG | 0.00x | US#12/3,111 Sec#1/94 |
| P/S | 3.54x | US#1,975/3,111 Sec#79/94 |
| EV/EBITDA | 10.01x | US#774/3,111 Sec#52/94 |
| FCF Yield | 4.55% | US#1,408/3,111 Sec#76/94 |
| Profitability | ||
| ROE | 15.47% | US#836/3,111 Sec#41/94 |
| ROA | 3.99% | US#1,203/3,111 Sec#42/94 |
| Op. Margin | 30.97% | US#414/3,111 Sec#15/94 |
| Revenue Growth | 24.96% | US#610/3,111 Sec#17/94 |
| Earnings Growth | 3413.79% | US#14/3,111 Sec#1/94 |
| Financial Health | ||
| Debt Ratio | 288.10% | US#2,092/3,111 Sec#41/94 |
| Total Debt | $7.91B | US#490/3,111 Sec#13/94 |
| FCF | $2.93B | US#255/3,111 Sec#21/94 |
| Cash | $5.65B | US#178/3,111 Sec#9/94 |
| Current Ratio | 8.86x | US#276/3,111 Sec#9/94 |
| Net Debt/EBITDA | 0.34x | US#741/3,111 Sec#39/94 |
| Dividend | ||
| Div. Yield | 1.85% | US#988/3,111 Sec#38/94 |
| Div. Growth | 16.00% | US#321/3,111 Sec#7/94 |
| Performance | ||
| 1Y Return | 31.25% | US#1,154/3,111 Sec#20/94 |
| 1M Return | 4.82% | US#648/3,111 Sec#20/94 |
| From 52W High | -2.70% | US#155/3,111 Sec#11/94 |
| 1Y MDD | -9.11% | US#39/3,111 Sec#4/94 |
| Trading | ||
| Volume | 1,278,797 shares | US#1,322/3,111 Sec#21/94 |
| Trading Value | $163M | US#684/3,111 Sec#13/94 |
| Per Share | ||
| EPS | $6.88 | US#432/3,111 Sec#35/94 |
| BPS | $55.64 | US#355/3,111 Sec#37/94 |
Company Info
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company also provides hearing, final expense, pet, Medicare supplement, supplemental dental and vision, short-term disability, and absence management insurance products, as well as cafeteria plans. It sells its products to individuals, families, and business owners through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.